| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |